We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pair of Molecular Regulators Maintains Normal Eosinophil Levels

By LabMedica International staff writers
Posted on 18 Nov 2013
An international team of cell biologists have identified the mechanism that regulates production of eosinophils by the blood marrow, which may lead to development of drugs to control diseases caused by an excess of these cells.

Eosinophils are immune cells responsible for combating certain infections such as multicellular parasites. More...
Along with mast cells, they also control mechanisms associated with allergy and asthma. Eosinophils develop in the bone marrow under the control of the central eosinophil growth factor interleukin 5 (IL-5) before migrating into the blood. In normal individuals, eosinophils make up about 1%–6% of white blood cells, and are about 12–17 micrometers in size. Under normal conditions, eosinophils are found in the medulla and the junction between the cortex and medulla of the thymus and in the lower gastrointestinal tract, ovary, uterus, spleen, and lymph nodes but not in the lung, skin, or esophagus. The presence of eosinophils in these latter organs is associated with disease.

Investigators at Tel Aviv University (Israel) and Cincinnati Children's Hospital Medical Center (Ohio, USA) searched for the molecular signals that regulate eosinophil production.

They reported in the November 10, 2013, online edition of the journal Nature Immunology that IL-5 activity in eosinophils was regulated by the paired immunoglobulin-like receptors PIR-A and PIR-B. PIR-A countered the activity of IL-5 and triggered eosinophil apoptosis. However, in eosinophilia the activity of PIR-A was blocked by overexpression of PIR-B, and the eosinophils did not die.

Experiments using a model system of asthmatic mice that lacked PIR-B showed that these animals had little expansion of eosinophils in their blood and lungs and less asthmatic inflammation in their lungs than normal mice. The lack of PIR-B prevented eosinophils from reaching harmful levels.

"The fundamental knowledge we have gained may one day yield new therapies to treat devastating eosinophilic disorders," said senior author Dr. Ariel Munitz, senior lecturer in microbiology and clinical immunology at Tel Aviv University.

Researchers are now seeking drugs to either enhance the toxic effect of PIR-A on eosinophils or to weaken PIR-B activity in order to reduce its inhibitory effect on PIR-A.

Related Links:

Tel Aviv University
Cincinnati Children's Hospital Medical Center



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Collection and Transport System
PurSafe Plus®
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.